SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 28 filers reported holding SINOVAC BIOTECH LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | – | 17,029 | -0.1% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 17,052 | -1.0% | 0.00% | -100.0% |
| Q1 2022 | $111,000 | -0.9% | 17,220 | -0.9% | 0.01% | +25.0% |
| Q4 2021 | $112,000 | -2.6% | 17,385 | -2.0% | 0.01% | -11.1% |
| Q3 2021 | $115,000 | -0.9% | 17,739 | -0.8% | 0.01% | 0.0% |
| Q2 2021 | $116,000 | -0.9% | 17,879 | -48.8% | 0.01% | 0.0% |
| Q1 2021 | $117,000 | -1.7% | 34,898 | +90.0% | 0.01% | -30.8% |
| Q4 2020 | $119,000 | -1.7% | 18,372 | -1.8% | 0.01% | 0.0% |
| Q3 2020 | $121,000 | -9.0% | 18,713 | -9.3% | 0.01% | -7.1% |
| Q2 2020 | $133,000 | -0.7% | 20,626 | -0.3% | 0.01% | +16.7% |
| Q1 2020 | $134,000 | 0.0% | 20,691 | -0.0% | 0.01% | 0.0% |
| Q4 2019 | $134,000 | 0.0% | 20,698 | -0.1% | 0.01% | 0.0% |
| Q3 2019 | $134,000 | 0.0% | 20,727 | -0.2% | 0.01% | +9.1% |
| Q2 2019 | $134,000 | -0.7% | 20,759 | -0.4% | 0.01% | 0.0% |
| Q1 2019 | $135,000 | -53.4% | 20,851 | -50.0% | 0.01% | -52.2% |
| Q4 2018 | $290,000 | -4.0% | 41,733 | -4.9% | 0.02% | +21.1% |
| Q3 2018 | $302,000 | -3.2% | 43,902 | +5.0% | 0.02% | 0.0% |
| Q2 2018 | $312,000 | -77.2% | 41,828 | -73.7% | 0.02% | -72.9% |
| Q1 2018 | $1,369,000 | +11.0% | 158,993 | +1.6% | 0.07% | +11.1% |
| Q4 2017 | $1,233,000 | +17.0% | 156,492 | +4.6% | 0.06% | +8.6% |
| Q3 2017 | $1,054,000 | -0.4% | 149,539 | -4.6% | 0.06% | -3.3% |
| Q2 2017 | $1,058,000 | +18.5% | 156,779 | +0.6% | 0.06% | +15.4% |
| Q1 2017 | $893,000 | -13.5% | 155,796 | -11.0% | 0.05% | -20.0% |
| Q4 2016 | $1,032,000 | -21.1% | 174,966 | -21.0% | 0.06% | -22.6% |
| Q3 2016 | $1,308,000 | -3.4% | 221,611 | -3.0% | 0.08% | -8.7% |
| Q2 2016 | $1,354,000 | -3.1% | 228,350 | +4.5% | 0.09% | -8.9% |
| Q1 2016 | $1,397,000 | +1.5% | 218,556 | -9.2% | 0.10% | -2.9% |
| Q4 2015 | $1,377,000 | +229.4% | 240,674 | +6472.2% | 0.10% | +141.9% |
| Q3 2015 | $418,000 | -49.4% | 3,662 | -97.7% | 0.04% | -49.4% |
| Q2 2015 | $826,000 | +49.1% | 157,295 | +40.8% | 0.08% | +39.3% |
| Q1 2015 | $554,000 | +87.2% | 111,746 | +97.7% | 0.06% | +60.5% |
| Q4 2014 | $296,000 | +181.9% | 56,519 | +159.8% | 0.04% | +100.0% |
| Q3 2014 | $105,000 | – | 21,758 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 2,718,735 | $340,500,000 | 6.32% |
| Vivo Capital, LLC | 5,900,000 | $38,173,000 | 4.21% |
| Neumann Advisory Hong Kong Ltd | 315,586 | $2,042 | 0.72% |
| Yorktown Management & Research Co Inc | 74,893 | $485,000 | 0.63% |
| Skandinaviska Enskilda Banken AB (publ) | 40,000 | $259,000 | 0.00% |
| Renaissance Technologies | 2,375,841 | $1,537,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,687 | $11,000 | 0.00% |
| NORTHERN TRUST CORP | 13,787 | $55,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 412 | $27,000 | 0.00% |